ArticleJournal of oncology practice2017
Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.
Article in Journal of oncology practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Impact of a New Gynecologic Oncology Hashtag During Virtual-Only ASCO Annual Meetings: An X (Twitter) Social Network Analysis.JMIR medical education · 2024Article
- Embracing the (r)evolution of social media and digital scholarship in pediatric nephrology education.Pediatric nephrology (Berlin, Germany) · 2024Review
- The Lancet Commission on prostate cancer: planning for the surge in cases.Lancet (London, England) · 2024Review
- The New Media Landscape and Its Effects on Skin Cancer Diagnostics, Prognostics, and Prevention: Scoping Review.JMIR dermatology · 2024Article
- Audience reconstructed: social media interaction by BTS fans during live stream concerts.Frontiers in psychology · 2024Article
- Analysis of Fluoride-Free Content on Twitter: Topic Modeling Study.Journal of medical Internet research · 2023Article
- Social Media and Professional Development for Oncology Professionals.JCO oncology practice · 2022Review
- Netiquette for social media engagement for oncology professionals.Future oncology (London, England) · 2022Review
- Oncofertility and Fertility Preservation in Cancer Patients Across the Twitterverse.Frontiers in endocrinology · 2022Observational
- The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.Current oncology reports · 2021Review
- Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Article
- Research Interest and Public Interest in Melanoma: A Bibliometric and Google Trends Analysis.Frontiers in oncology · 2021Article
- Article
- COVID-19 and information and communication technology in radiation oncology: A new paradigm.World journal of clinical oncology · 2020Article
- Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.Current hematologic malignancy reports · 2020Review
- Social Media for Hematopathologists: Medical Practice Reinvented-#Hemepath.Current hematologic malignancy reports · 2020Review
- Two-Year Experience in "Tweeting the Meeting" During the Scientific Sessions - Rapid Report From the Japanese Circulation Society.Circulation reports · 2020Article
- Leveraging Social Media for Cardio-Oncology.Current treatment options in oncology · 2020Review
- Physician-initiated Research in Social Media. An Area That Can No Longer Be Ignored.ATS scholar · 2020Article
- Potential Role of Twitter at an Annual Congress in Japan - Narrative Literature Review of "Tweet the Meeting".Circulation reports · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThe use of social media, in particular Twitter, has substantially increased among health care stakeholders in the field of hematology and oncology, with an especially sharp increase in the use of Twitter during times of major national meetings. The most attended meeting in the oncology field is the ASCO annual meeting. Little is known about the detailed metrics involved in the use, volume, and impact of Twitter during the ASCO annual meeting.
methodsWe conducted a retrospective review of tweets during the ASCO annual meetings from 2011 to 2016. The total data set encompassed 190,732 tweets from 39,745 authors over six consecutive ASCO meetings from 2011 to 2016 (inclusive). Tweets, all publically available, were collected by Nephrology On-Demand Analytics.
resultsThe number of individual authors increased from 1,429 during the 2011 ASCO meeting to 15,796 during the 2016 ASCO meeting, an 11-fold increase over the total 5-year period. There was a notable increase in tweets from the 2011 ASCO meeting (n = 7,746) to the 2016 ASCO meeting (n = 72,698), a nine-fold increase during the study period. The most commonly tweeted term or topic changed over time, generally reflecting the breakthroughs of each designated year; these terms were "melanoma" for both the 2011 and 2012 ASCO meetings; "breast cancer" for the 2013 ASCO meeting; "lung cancer" for the 2014 ASCO meeting; and "ImmunOnc" or "immunotherapy/immuno-oncology" for both the 2015 and 2016 ASCO meetings.
conclusionThe use of Twitter among health care stakeholders during the ASCO meeting has markedly increased over time, demonstrating the increasing role of social media in the dissemination of findings at the most highly attended hematology and oncology conference of the year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.